Your Article Summary
Antigenics Receives NASDAQ Delisting Notice
Antigenics, 02/13/09
Antigenics Inc. announced that it received a letter, as expected, from the Listing Qualifications Staff of The NASDAQ Stock Market LLC indicating that it had not regained compliance with Marketplace Rule 4450, requiring a minimum $50 million market value of listed securities for continued inclusion on The NASDAQ Global Market.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
Visanne cleared for market launch in Europe as new treatment option for endometriosis
BayNews International, 12/08/09
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Bristol Myers-Squibb Company, 12/07/09
Article Search
Sponsor


See Latest Articles


